Search
Precision Oncology: Diagnostics, Biomarker-Driven Therapies and Payer Considerations
- Aug 28
- 1 min read
Author: Jennifer Billings
Jennifer Billings, PharmD, BCGP, Senior Director of Clinical Pharmacy at IPD Analytics, presented "Precision Oncology: Diagnostics, Biomarker-Driven Therapies and Payer Considerations" at the AMCP Great Plains Day of Education (DOE) on August 28, 2026, at 10:20 AM CT.
The session explored how biomarker-driven therapies and companion diagnostics are reshaping oncology treatment pathways and what payers need to consider as precision oncology continues to evolve.
